Of note, TNF-α+IL-17 facilitated CFTR modulator responses such that they lowered CF ASL viscosity toward its optimal value, an effect that was not observed when modulators were applied in the absence of cytokines. The gene discussed is CFTR; the disease is cystic fibrosis.